Results 281 to 290 of about 12,874,292 (410)
Resolvin D1 values in patients with alcohol-associated liver disease. [PDF]
Küçük İ, Salmanoğlu M, Baş S.
europepmc +1 more source
Effects of Non‐Aspirin Nonsteroidal Anti‐Inflammatory Drugs on Acute Intracerebral Hemorrhage
ABSTRACT Objective Despite celecoxib, a cyclooxygenase‐2 inhibitor, promoting functional recovery from intracerebral hemorrhage (ICH) by reducing inflammation‐mediated perihematomal edema in rat models, the evidence of its effects on patient outcomes remains limited.
Shin‐Joe Yeh +3 more
wiley +1 more source
Advanced alcoholic liver disease driven by a proferroptotic diet. [PDF]
Liang Y +10 more
europepmc +1 more source
Durability of Response to B‐Cell Maturation Antigen‐Directed mRNA Cell Therapy in Myasthenia Gravis
ABSTRACT Objective We report the 12‐month follow‐up outcomes from a Phase 2 clinical trial (NCT04146051) evaluating Descartes‐08, a BCMA‐directed RNA chimeric antigen receptor T‐cell (rCAR‐T) therapy for refractory generalized myasthenia gravis (MG).
Nizar Chahin +10 more
wiley +1 more source
Alcohol Consumption Behaviors and Liver Disease: Is There a Safer Drinking Practices? [PDF]
Ding S, Lu S, Lv W, Hou F, Qi X, Liu X.
europepmc +1 more source
Bile acids for metabolic dysfunction-associated steatotic liver disease in adults. [PDF]
Ashmawy RE +5 more
europepmc +1 more source
A peculiar disease of the liver. Edelmann (Wienerkl. Woch., 1926, no. 43)
openalex +2 more sources

